Clinical Trials with Precision

Lean into Aster Insights’ network service and product offerings to expedite your recruitment and accelerate enrollment for biomarker targeted oncology clinical trials, better predict treatment response, and match patients to the optimal therapies for the best possible outcome.

Optimize Patient Cohorts

Find Patients Faster

Expand Your Insights

Leverage Lifetime Tracking

Accelerate Enrollment & Offer Opportunity

On average 20% of clinical trials for cancer cannot be completed because not enough patients join (ASCO Educational Book 36, May 2016). The right patients for your clinical trials are waiting for the opportunity.

Through our one-of-a-kind partnership among the key stakeholders in cancer research, we can find the right patients for your studies. Our network based offering enables rapid identification of eligible patients, trial acceptance and enrollment, and we have the network in place to ensure they get invited to participate. Tell us your ideal patient cohort, and we’ll help you find, enroll, and follow-up with patients—efficiently and with precision.


Expedite Your Target-based Clinical Trials

Aster Insights helps oncology researchers overcome the challenge of identifying, reaching, and inviting the right patients to enroll in clinical trials, offering a win-win scenario for both researchers and patients. We use a unique and proactive approach to rapidly identify cancer patients, reduce your study timelines and costs, and provide patients with opportunities to treatment options that can only be accessed through precise clinical trial matching.

Optimize Patient Cohorts

Enroll patients based on cancer type, molecular signatures, and clinical characteristics.

Find Patients Faster

Leverage our bioinformatics solutions and streamlined communication network for identifying patients.

Expand Your Insights

Gain actionable data and elevate your study design with rich clinicogenomic patient data.

Leverage Lifetime Tracking

Identify patients for clinical trials at any point in their journey and monitor response to treatment over time.

Lean Into Our One-of-a-Kind Alliance

By bringing together a diverse cross-section of patients, clinicians, and researchers through our patented Total Cancer Care® (TCC) protocol and the Oncology Research Information Exchange Network® (ORIEN), Aster Insights is helping clinical researchers accelerate the development and delivery of personalized cancer therapies that can potentially help countless patients worldwide.

Total Cancer Care Clinical Registry

The TCC is the most comprehensive consented cancer patient registry available with over 350,000 patients and growing.


With AVATAR, we can rapidly identify eligible patients for trials by running inquiries across 30+ cancer types within the TCC registry.

ORIEN Cancer Centers

There are 18 ORIEN members across the nation, each implementing the TCC protocol and leveraging a direct line to physicians and Aster Insights.

ORIEN Clinical Trials Network

The OCTN provides the ability to identify patients for target-based clinical trials and offers a centralized SRC and centralized IRB.

It starts with lifetime patient consent to our patented Total Cancer Care® (TCC) protocol, donating their de-identified longitudinal clinical data and molecular data from tumor tissue specimens. This results in a continuously expanding database of rich clinicogenomic data.

Researchers can access the database, identifying patients who have the cancer type and biomarkers that match specific trial inclusion/exclusion criteria. They can then leverage our bioinformatics and data collection experts to assist with clinical trial design.

From here we coordinate with ORIEN and physicians to use the ORIEN TCC shared research database to find these patients and invite the patients to join the clinical trial.

The patients get the opportunity to decide if they want to join and you have an easy path to enroll patients.


Working Tirelessly Bring a Brighter Future to Cancer Patients

Tackling cancer is personal, on a human level and a molecular level, and our goal is to help people survive and thrive.

But we can’t do it alone. It requires a community of partners working together—patients, cancer research centers, and drug developers—to take on this life altering, highly complex disease. Partners who are in it for as long as it takes, from lifetime-consented patients to long-term disease research studies and drug development programs.

Watch Aster Insights Intro Video


Featured Publication

Related Products & Services


Get answers to targeted oncology research questions by tapping into industry experts at Aster Insights and letting us SEARCH the AVATAR database for you.